At DSM Pharmaceutical Products, development of your project is embraced at any
stage in the process. Whether you’re in Phase I, Phase II, Phase III or ready
to go commercial, we can help you move your project in and out of development.
Leveraging expertise in a variety of disciplines and at a variety of
manufacturing facilities, DSM Pharmaceutical Products can and will move your
project from concept to completion.
Through the use of Chiral Technologies, we can bring to the surface what you
need and when you need it to complete the cycle of chiral production. These
include enantio- and diastereomerically pure chiral building blocks. We
approach it in an integrated manner in which a combination of proprietary
technologies are use alongside our single competencies including biocatalysis,
homogeneous catalysis and oxidation.
For our biopharmaceutical customers, our Groningen, Netherlands manufacturing
facility offers the scope and infrastructure necessary to meet your
needs. Whether you’re delivering monoclonal antibodies or proteins, Groningen
has the integrated approach to biopharmaceutical production that guarantees a
quality product.
We can further your development stream through a dedicated early phase
development team centralized under the unit of Rescom®, which stands for
responsive and committed, our customers have at their disposal a proven team
that is taking projects from pre-clinical all the way through to
commercial. Comprised of 40 researchers in state-of-the-art laboratories,
Rescom drives your project through the project pipeline, whatever stage you’re
in----preclinical, or stage III; whatever class of company you are ----
virtual or large pharma.
